本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aurinia Pharmaceuticals Inc

7.59
+0.10001.34%
盘后7.57-0.0200-0.26%16:49 EDT
成交量:100.85万
成交额:759.40万
市值:10.25亿
市盈率:28.53
高:7.61
开:7.51
低:7.45
收:7.49
数据加载中...
2019/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/13

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/11/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/25

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/09/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/13

员工持股计划

Securities to be offered to employees in employee benefit plans
2019/08/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/21

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/04

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/05/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]